Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-01-25

Clinical Trial Update: Open Label Trial of Aripiprazole in Children and Adolescents With Tourette's Disorder [Phase 4]

View source ↗

Summary

Open-label Phase 4 trial of aripiprazole in children and adolescents with Tourette's disorder completed; results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: NYU Langone Health | Conditions: Tourette's Syndrome, Tic Disorders | Phase 4 | Status: COMPLETED | Results posted: 2013-01-25